PAHC
Price
$21.69
Change
-$0.12 (-0.55%)
Updated
Dec 20, 04:59 PM (EDT)
44 days until earnings call
PBH
Price
$78.67
Change
+$0.02 (+0.03%)
Updated
Dec 20, 04:59 PM (EDT)
45 days until earnings call
Ad is loading...

PAHC vs PBH

Header iconPAHC vs PBH Comparison
Open Charts PAHC vs PBHBanner chart's image
Phibro Animal Health
Price$21.69
Change-$0.12 (-0.55%)
Volume$11K
CapitalizationN/A
Prestige Consumer Healthcare
Price$78.67
Change+$0.02 (+0.03%)
Volume$971
CapitalizationN/A
PAHC vs PBH Comparison Chart
Loading...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PAHC vs. PBH commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a Hold and PBH is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (PAHC: $21.69 vs. PBH: $78.72)
Brand notoriety: PAHC and PBH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PAHC: 482% vs. PBH: 211%
Market capitalization -- PAHC: $523.71M vs. PBH: $3.6B
PAHC [@Pharmaceuticals: Other] is valued at $523.71M. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 2 FA rating(s) are green whilePBH’s FA Score has 2 green FA rating(s).

  • PAHC’s FA Score: 2 green, 3 red.
  • PBH’s FA Score: 2 green, 3 red.
According to our system of comparison, PBH is a better buy in the long-term than PAHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 4 TA indicator(s) are bullish while PBH’s TA Score has 5 bullish TA indicator(s).

  • PAHC’s TA Score: 4 bullish, 6 bearish.
  • PBH’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PBH is a better buy in the short-term than PAHC.

Price Growth

PAHC (@Pharmaceuticals: Other) experienced а -4.32% price change this week, while PBH (@Pharmaceuticals: Other) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

PAHC is expected to report earnings on Feb 05, 2025.

PBH is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.6B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than PBH: PAHC (34.11) vs PBH (14.90). PAHC YTD gains are higher at: 92.422 vs. PBH (28.585). PAHC has higher annual earnings (EBITDA): 83.7M vs. PBH (10.8M). PAHC has more cash in the bank: 92.5M vs. PBH (63.6M). PAHC has less debt than PBH: PAHC (513M) vs PBH (1.21B). PBH has higher revenues than PAHC: PBH (1.13B) vs PAHC (982M).
PAHCPBHPAHC / PBH
Capitalization524M3.6B15%
EBITDA83.7M10.8M775%
Gain YTD92.42228.585323%
P/E Ratio34.1114.90229%
Revenue982M1.13B87%
Total Cash92.5M63.6M145%
Total Debt513M1.21B42%
FUNDAMENTALS RATINGS
PAHC vs PBH: Fundamental Ratings
PAHC
PBH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
969
SMR RATING
1..100
8061
PRICE GROWTH RATING
1..100
4248
P/E GROWTH RATING
1..100
632
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (24) in the Pharmaceuticals Major industry is somewhat better than the same rating for PBH (76) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for PAHC (96) in the Pharmaceuticals Major industry. This means that PBH’s stock grew significantly faster than PAHC’s over the last 12 months.

PBH's SMR Rating (61) in the Pharmaceuticals Other industry is in the same range as PAHC (80) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as PBH (48) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to PBH’s over the last 12 months.

PAHC's P/E Growth Rating (6) in the Pharmaceuticals Major industry is in the same range as PBH (32) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCPBH
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
54%
MACD
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
47%
Advances
ODDS (%)
Bullish Trend 14 days ago
71%
Bullish Trend 21 days ago
60%
Declines
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 4 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
57%
View a ticker or compare two or three
Ad is loading...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDAX9.580.13
+1.38%
MassMutual Diversified Value A
GTMTX23.470.22
+0.95%
Goldman Sachs Small/Mid Cap Growth Inv
PLAEX30.210.14
+0.47%
Plumb Equity A
MEMBX30.270.03
+0.10%
MFS Emerging Markets Equity B
NEMIX19.69-0.05
-0.25%
Neuberger Berman Emerg Mkts Eq I

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-0.55%
PBH - PAHC
34%
Loosely correlated
+0.08%
SCYX - PAHC
27%
Poorly correlated
-1.00%
EVO - PAHC
27%
Poorly correlated
+1.59%
AMPH - PAHC
25%
Poorly correlated
-0.63%
ALKS - PAHC
25%
Poorly correlated
-0.87%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.08%
PAHC - PBH
36%
Loosely correlated
-0.55%
IRWD - PBH
32%
Poorly correlated
+14.69%
SUPN - PBH
29%
Poorly correlated
-0.95%
EBS - PBH
26%
Poorly correlated
+0.50%
VTRS - PBH
24%
Poorly correlated
+3.22%
More